Cantor Fitzgerald Predicts AQST FY2026 Earnings
Aquestive Therapeutics, Inc. (NASDAQ:AQST – Free Report) – Cantor Fitzgerald issued their FY2026 earnings estimates for shares of Aquestive Therapeutics in a report released on Monday, June 9th. Cantor Fitzgerald analyst K. Kluska anticipates that the company will post earnings of ($0.81) per share for the year. The consensus estimate for Aquestive Therapeutics’ current full-year […]
